India, Oct. 14 -- MindBio Therapeutics Corp. (WF60.F), a biotechnology company developing AI-driven voice analytics for drug and alcohol intoxication detection, announced that it has completed manufacturing its next-generation Edge AI Intoxication Detection Kiosk as it advances software integration and testing ahead of a planned initial commercial pilot.
The newly manufactured kiosk builds on an initial prototype developed in June 2026 and is designed to support MindBio's proprietary Voice AI technology. The system analyzes characteristics of the human voice to predict potential impairment associated with drug and alcohol consumption.
MindBio is continuing software integration, system testing and validation of its predictive AI models aga...